BILIARY TRACT NEOPLASMS IMMUNOTHERAPY

Clinical trials for BILIARY TRACT NEOPLASMS IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new BILIARY TRACT NEOPLASMS IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for BILIARY TRACT NEOPLASMS IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat bile duct cancer

Disease control Recruiting now

This study is testing three different first-line treatment combinations for advanced bile duct cancer. It will compare an immunotherapy drug (pembrolizumab) given alone, with chemotherapy, or with another targeted drug (lenvatinib). The goal is to see which approach best controls…

Matched conditions: BILIARY TRACT NEOPLASMS IMMUNOTHERAPY

Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

BILIARY TRACT NEOPLASMS IMMUNOTHERAPY

Get alerted when new BILIARY TRACT NEOPLASMS IMMUNOTHERAPY trials appear

New hope for Tough-to-Treat bile duct cancer